宣捷幹細胞 (4724.TW) 2025Q2 financial report shows revenue of 250.42M TWD, with a YoY growth rate of 92.14%. This outstanding figure clearly proves the company’s exceptionally strong operational momentum and significant expansion in market demand. To accurately capture 宣捷幹細胞 (4724.TW)’s future growth potential, investors should closely follow subsequent financial reports and key strategic movements, and deeply integrate diversified data and tools such as Growin AI Value Analysis for a comprehensive and forward-looking strategic assessment.